AI-Powered smartphone test could revolutionize cervical cancer screening
NCT ID NCT06815939
First seen Jan 26, 2026 · Last updated Apr 29, 2026 · Updated 14 times
Summary
This study tests a new, low-cost screening tool for cervical cancer that uses artificial intelligence to analyze digital images of the cervix, without needing a lab. It aims to see if this automated visual evaluation (AVE) can accurately detect precancerous changes in women aged 30 to 59. The tool could make screening more accessible in low-resource settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE CERVICAL NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ministerio de Salud
RECRUITINGSan Salvador, El Salvador
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.